Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Expanded access use of Itacitinib to treat a single patient with aplastic anemia.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Itacitinib | Drug |
|
Inclusion Criteria:
-
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Incyte Corporation Call Center (US) | Contact | 1.855.463.3463 | medinfo@incyte.com |
| Name | Affiliation | Role |
|---|---|---|
| Lisa Forbes Satter, MD | Baylor College of Medicine | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| C000718170 | itacitinib |
| C000603457 | INCB039110 |
Not provided
Not provided
Not provided